3629 results for «899»
3629 results
Align for the future with structural heart innovations - LIVE case and major trial updates
19 May 2026 – From EuroPCR 2026
Stay abreast of structural heart innovations with expert discussions on best-in-class transcatheter aortic valve implantation (TAVI) practices, including imaging, sizing, and procedural strategies. This session with LIVE case introduces the novel Myval Octapro+ transcatheter heart valve (THV), its design philosophy, and potential clinical benefits, along with...
Left main PCI treatment: how Ultreon 3.0 can improve decision making and achieve optimised outcomes
20 May 2026 – From EuroPCR 2026
This session explores how to optimise left main PCI through the integration of intracoronary imaging and physiology using Ultreon 3.0 software. It highlights how this innovative technology supports decision-making, procedural planning, and stent optimisation to improve outcomes in complex lesion management.
Expanding the horizon - Trials addressing unchartered territories in coronary and structural heart
20 May 2026 – From EuroPCR 2026
New clinical evidence is pushing coronary and structural heart therapy into areas that were previously uncertain or inconsistently defined, with multiple landmark trials now shaping future practice.
Among the studies discussed in this EuroPCR 2026 session, are SORT OUT XII, START YOUNG, BISCUSPID, LANDMARK 2 and RESTORE...
Beyond the horizon - Future of structural heart innovations and PCI
20 May 2026 – From EuroPCR 2026
Structural heart and coronary interventions are expanding rapidly, with innovation increasingly focused on managing complex anatomies and diversifying treatment strategies.
The PRISM-PCI toolkit is introduced as a framework to support decision-making in complex PCI, alongside advances in transcatheter valve therapies spanning mitral, tricuspid and pulmonary interventions, as...
Novelties in epicardial physiology: PPG explained in a simulated environment
20 May 2026 – From EuroPCR 2026
Understanding coronary physiology continues to evolve as new indices aim to refine how epicardial disease is assessed in daily practice.
The perfusion pressure gradient (PPG) index is introduced in this EuroPCR 2026 session as a novel approach to characterising epicardial coronary physiology. Rather than relying solely on...
TAVI for degenerated surgical aortic bioprotheses: procedural challenges
19 May 2026 – From EuroPCR 2026
This session addresses the procedural challenges inherent in transcatheter aortic valve implantation (TAVI) for degenerated surgical aortic bioprostheses. It covers high-risk valve-in-valve implantation cases as last-resort therapies, management of drifting bioprostheses, and interventions in failed small non-fracturable valves threatening coronary arteries. Techniques such as BASILICA and...
Advancing mitral transcatheter edge-to-edge repair in complex lesions
20 May 2026 – From EuroPCR 2026
Learn how advanced imaging, careful anatomical assessment and tailored procedural strategies are helping expand the possibilities of mitral transcatheter edge-to-edge repair (M-TEER) in complex lesions.
Focusing on atrial secondary mitral regurgitation (SMR) and commissural mitral regurgitation, this EuroPCR 2026 session reviews evidence, showing that M-TEER can be...
Seeing differently, treating better: advanced imaging shaping modern structural heart practice
20 May 2026 – From EuroPCR 2026
This session explores the transformative role of advanced imaging, particularly 3D intracardiac echocardiography (ICE), in modern structural heart interventions. It provides practical insights into implementation, highlighting how these tools can enhance workflow efficiency and procedural confidence across transcatheter edge-to-edge repair (TEER), left atrial appendage (LAA) closure,...
From left to right: different perspectives on heart failure management
19 May 2026 – From EuroPCR 2026
Exploring diverse perspectives on heart failure management, this session presents a range of complex clinical cases. Topics include facilitated treatment of post-myocardial infarction interventricular septal defects, left ventricular perforation following Impella placement, diagnostic challenges in shock scenarios, the implications of severe right ventricular dysfunction on left...
From access to reperfusion: a procedural deep dive into pulmonary embolism
20 May 2026 – From EuroPCR 2026
From vascular access to reperfusion strategy, managing acute pulmonary embolism requires rapid decision-making, careful patient selection and increasingly sophisticated interventional techniques.
This EuroPCR 2026 session takes a procedural deep dive into contemporary pulmonary embolism management, focusing on thrombus aspiration techniques and the evolving role of computer-assisted vacuum...
Value of imaging for treatment of calcified lesions
19 May 2026 – From EuroPCR 2026
This session highlights the critical value of imaging in the treatment of calcified coronary lesions. It reviews techniques for lesion modification, including innovative balloon-based strategies and multimodality approaches for balloon-uncrossable calcified left main bifurcations. The session also discusses the tactical cracking of calcified plaques and strategies...
Best clinical CTO cases
19 May 2026 – From EuroPCR 2026
This session presents exemplary clinical cases in chronic total occlusion (CTO) PCI, illustrating advanced procedural strategies and complication management. Cases include retrograde CTO-PCI complicated by catheter-induced dissection, expansion of antegrade CTO PCI limits with hybrid approaches, successful combined antegrade and retrograde hydrodynamic contrast recanalisation, and staged...
PRISM-PCI - From clarity to cure
20 May 2026 – From EuroPCR 2026
PRISM-PCI offers cutting-edge imaging innovations and treatment strategies aimed at optimizing complex PCI procedures. This session explores the 'leave nothing behind' concept with thin-strut bioresorbable scaffolds and sirolimus drug-coated balloons, updates on ultra thin-strut DES platforms, including the SORT OUT XII trial, and introduces a comprehensive...
Evidence for new devices in management of coronary artery disease
19 May 2026 – From EuroPCR 2026
This session reviews the latest evidence on new devices in coronary artery disease management. It covers outcomes from randomized controlled trials including imaging- and physiology-guided PCI with the Bioadaptor device, long-term results of thinner-strut bioresorbable scaffolds, site-specific antithrombotic therapy evaluated in the DESyne BDS Plus Trial,...
The continuum of valvular heart disease: a lifetime management approach
21 May 2026 – From EuroPCR 2026
This session offers a comprehensive perspective on valvular heart disease through the lens of lifetime management, highlighting the need for strategic planning across aortic, mitral, and tricuspid interventions, illustrating how treating one valve can influence the progression and management of others. Gain insights into optimal timing...
Navigating high-thrombus burden in ACS: precision aspiration thrombectomy with CAT RX
21 May 2026 – From EuroPCR 2026
This session explores the challenges of managing high thrombus burden in patients with acute coronary syndromes (ACS), with a focus on precision aspiration thrombectomy using the CAT RX device. Through case-based examples, it provides practical insights into procedural techniques and examines the role of CAT RX...
Clinical cases - Nurses and Allied Professionals
19 May 2026 – From EuroPCR 2026
Dedicated to nurses and allied health professionals, this session presents compelling clinical cases illustrating their critical role in interventional cardiology. Topics range from managing pregnant patients in the cath lab, the impactful contributions of nursing and allied professionals (NAPs), to their management perspectives during complex procedures...
Clinical experience with transcatheter tricuspid valve replacement
19 May 2026 – From EuroPCR 2026
This session shares clinical experience with transcatheter tricuspid valve replacement (TTVR) for severe tricuspid regurgitation. It includes outcomes after prior repair, analysis of stent frame geometry as a predictor of leaflet abnormalities, and assessments of functional and quality-of-life improvements with systems such as Evoque and MonarQ....
Real world practice inspiring new evidence generation in structural heart
21 May 2026 – From EuroPCR 2026
This LIVE case session showcases real-world clinical practice driving new evidence in structural heart interventions, with a focus on TAVI. It features expert insights into pre-procedural imaging and sizing, treatment strategies, procedural techniques, and post-procedural management. The session also introduces the novel Myval Octapro+ transcatheter heart...
Pulmonary embolism intervention: a turning point in defining success
21 May 2026 – From EuroPCR 2026
This session explores the evolving objectives of pulmonary embolism treatment, highlighting the shift from simple patient stabilisation to a more comprehensive approach to recovery. It introduces the novel Transforming Fixation (TFX) technology and its role in improving catheter stability and access to the pulmonary vasculature. Drawing...
